Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.060
0.00 (0.00%)
May 26, 2026, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $313.64 million as of May 27, 2026. Its market cap has increased by 79.48% in one year.
Market Cap
313.64M
Enterprise Value
243.70M
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.06
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 313.64M, a decrease of -41.74%. That is a compound annual growth rate of -9.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 313.64M | 9.21% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 464.12M |
| Northwest Biotherapeutics | 387.08M |
| Vaxart | 156.02M |
| Glorywin Entertainment Group | 149.60M |
| NDT Pharmaceuticals | 118.13M |
| HST Global | 117.39M |
| Sangamo Therapeutics | 72.21M |
| BioStem Technologies | 70.12M |